|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2003-6-10
|
|
pubmed:abstractText |
The benefit of thromboprophylaxis for 1 month has never been evaluated in patients undergoing hip fracture surgery, a setting in the highest risk category for postoperative venous thromboembolism (VTE).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0003-9926
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
9
|
|
pubmed:volume |
163
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1337-42
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12796070-Adult,
pubmed-meshheading:12796070-Aged,
pubmed-meshheading:12796070-Aged, 80 and over,
pubmed-meshheading:12796070-Double-Blind Method,
pubmed-meshheading:12796070-Drug Administration Schedule,
pubmed-meshheading:12796070-Female,
pubmed-meshheading:12796070-Fibrinolytic Agents,
pubmed-meshheading:12796070-Hip Fractures,
pubmed-meshheading:12796070-Humans,
pubmed-meshheading:12796070-Injections, Subcutaneous,
pubmed-meshheading:12796070-Male,
pubmed-meshheading:12796070-Middle Aged,
pubmed-meshheading:12796070-Polysaccharides,
pubmed-meshheading:12796070-Postoperative Complications,
pubmed-meshheading:12796070-Prospective Studies,
pubmed-meshheading:12796070-Pulmonary Embolism,
pubmed-meshheading:12796070-Venous Thrombosis
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.
|
|
pubmed:affiliation |
Orthopedics Department, Sahlgrenska University Hospital/Ostra, Göteborg, Sweden. b.eriksson@orthop.gu.se
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
